Genomics of MPN progression.

Anand A Patel1, Olatoyosi Odenike1

  • 1Section of Hematology/Oncology, Department of Medicine, The University of Chicago Medicine, Chicago, IL.

Summary

Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) involve genetic mutations driving disease progression. Understanding these genomic alterations is crucial for managing advanced MPNs and improving patient outcomes.